Study Links $35 Insulin Cap to Improved Treatment Adherence in Type 2 Diabetes
Research demonstrates that capping insulin costs at $35 per month significantly improves medication adherence among patients with type 2 diabetes, providing evidence for price control policies.
·1 source
